Abstract
Despite advances in medical and revascularization therapies, myocardial infarction remains a major cause of morbidity and mortality worldwide. Cell therapy is emerging as an aiding strategy designed to advance the treatment of heart disease through promotion of cardiomyocyte regeneration and stimulation of reparative angiogenesis. This issue of Pharmacology and Therapeutics collates expert reviews on special achievements in basic research and clinical exploitation, which underline the prospective value of stem cells in cardiovascular medicine.
| Translated title of the contribution | Stem cell therapy for cardiovascular regeneration: the beginning or the end of all hearts' hopes |
|---|---|
| Original language | English |
| Pages (from-to) | 1 - 2 |
| Number of pages | 2 |
| Journal | Pharmacology and Therapeutics |
| Volume | 129 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cardiovascular Diseases
- Health Care Costs
- Humans
- Quality of Life
- Regeneration
- Regenerative Medicine
- Stem Cell Transplantation
Fingerprint
Dive into the research topics of 'Stem cell therapy for cardiovascular regeneration: the beginning or the end of all hearts' hopes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver